Back to Search Start Over

Radiation doses from low-dose CT scans in SPECT/CT and PET/CT examinations: A survey in Germany.

Authors :
Rinscheid A
Janzen T
Alikhani B
Beer AJ
Braune A
Eberhardt N
Fechner D
Förster S
Freesmeyer M
Furth C
Grunert M
Hellwig D
Costa PF
Kühnel C
Lange C
Linke R
Razlaw N
Sack T
Schmidt D
Schütze C
Starke A
Tondera L
Wengenmair H
Zöphel K
Burchert W
Lapa C
Source :
Nuklearmedizin. Nuclear medicine [Nuklearmedizin] 2022 Aug; Vol. 61 (4), pp. 294-300. Date of Electronic Publication: 2022 Apr 06.
Publication Year :
2022

Abstract

Aim: Recently, dose reference levels (DRLs) have been defined in Germany for auxiliary low-dose CT scans in hybrid SPECT/CT and PET/CT examinations, based on data from 2016/17. Here, another survey from 2020 was evaluated and compared with the new DRLs as well as with similar surveys from foreign countries.<br />Methods: The survey, which had already been conducted in the Nordic countries, queried for various examinations including the following values: patient weight and height, volume CT dose index (CTDI <subscript>vol</subscript> ), dose length product (DLP). For each examination, statistical parameters such as the third quartile (Q3) were determined from all submitted CTDI <subscript>vol</subscript> and DLP values. Additionally, for examinations comprising datasets from at least 10 systems, the third quartile (Q3-Med) of the respective median values of each system was calculated. Q3 and Q3-Med were compared with the newly published DRLs from Germany and values from similar studies from other countries.<br />Results: Data from 15 SPECT/CT and 13 PET/CT systems from 15 nuclear medicine departments were collected. For the following examinations datasets from more than 10 systems were submitted: SPECT lung VQ, SPECT bone, SPECT&PET cardiac, PET brain, PET oncology. Especially for examinations of the thorax and heart, the new DRLs are very strict compared to this study. The CTDI <subscript>vol</subscript> values for examinations of the head were lower in this study than the DRLs prescribe now.<br />Conclusions: For certain examination types, there is a need for dose optimization at some clinics and devices in order to take into account the new DRLs in Germany in the future.<br />Competing Interests: The authors declare that they have no conflict of interest.<br /> (Thieme. All rights reserved.)

Details

Language :
English
ISSN :
2567-6407
Volume :
61
Issue :
4
Database :
MEDLINE
Journal :
Nuklearmedizin. Nuclear medicine
Publication Type :
Academic Journal
Accession number :
35388444
Full Text :
https://doi.org/10.1055/a-1759-3900